Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1

By Tonelli Francesco   Giudici Francesco   Giusti Francesca   Brandi Maria Luisa  

Cancers, Vol. 4, Iss. 2, 2012-05 ,pp. : 504-522

MDPI

Access to resources Recommend Favorite

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis

By Chiba Kenji   Adachi Kunitomo  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 514-528

MDPI

Access to resources Recommend Favorite

The Influence of AHI1 Variants on the Diagnosis and Treatment Outcome in Schizophrenia

By Porcelli Stefano   Pae Chi-Un   Han Changsu   Lee Soo-Jung   Patkar Ashwin A.   Masand Prakash S.   Balzarro Beatrice   Alberti Siegfried   De Ronchi Diana   Serretti Alessandro  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-01 ,pp. : 2517-2529

MDPI

Access to resources Recommend Favorite

Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency

By Daci Armond   Bozalija Adnan   Jashari Fisnik   Krasniqi Shaip  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 122-122

MDPI

Access to resources Recommend Favorite

Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice

By Schlegel Victoria   Thieme Markus   Holzmann Carsten   Witt Martin   Grittner Ulrike   Rolfs Arndt   Wree Andreas  

International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-11 ,pp. : 1866-1866

MDPI

Access to resources Recommend Favorite